Lancet clinical review paper: why absence of evidence is not evidence of absence by Andrew Proudfoot March 18, 2026March 18, 2026 After a review of historical clinical trials found limited evidence supporting medicinal cannabis for mental health […]
Prices continue to tumble as market sees rapid rise in product numbers by Adam Sheldon March 3, 2026March 5, 2026
AP approvals fall as medicinal cannabis sales plateau, Penington report finds by Adam Sheldon December 3, 2025December 4, 2025
‘Houston, we have a bit of a problem’: Chief TGA medical adviser flags systemic issues across sector by Adam Sheldon November 18, 2025February 21, 2026
TGA reviewing 751 submissions as industry outlines roadmap for reform by Adam Sheldon October 8, 2025October 8, 2025
Neurotech to release paediatric cannabis drug through Authorised Prescribers by Adam Sheldon September 24, 2025February 21, 2026
Montu calls for single prescriber framework in TGA submission by Adam Sheldon August 28, 2025August 28, 2025
Huge spike in approvals as TGA signs off 8,000 cannabis prescriptions in February by Steve Jones March 4, 2021April 26, 2024
